iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 2252

Identifiers

  • Canonical SMILES:
    Cn1ncc2cc(ccc12)C(=O)Nc1ccc2[nH]c(CN3CC4CC4C3)nc2c1
  • IUPAC name:
    N-[2-({3-azabicyclo[3.1.0]hexan-3-yl}methyl)-1H-1,3-benzodiazol-5-yl]-1-methyl-1H-indazole-5-carboxamide
  • InChi:
    InChI=1S/C22H22N6O/c1-27-20-5-2-13(6-14(20)9-23-27)22(29)24-17-3-4-18-19(8-17)26-21(25-18)12-28-10-15-7-16(15)11-28/h2-6,8-9,15-16H,7,10-12H2,1H3,(H,24,29)(H,25,26)
  • InChiKey:
    IGZWGTGHJXYZKT-UHFFFAOYSA-N

External links


168317845

External search

Bibliography (1)

Publication Name
Moustakim Moses, Christott Thomas, Monteiro Octovia P., Bennett James, Giroud Charline, Ward Jennifer, Rogers Catherine M., Smith Paul, Panagakou Ioanna, Díaz-Sáez Laura, Felce Suet Ling, Gamble Vicki, Gileadi Carina, Halidi Nadia, Heidenreich David, Chaikuad Apirat, Knapp Stefan, Huber Kilian V. M., Farnie Gillian, Heer Jag, Manevski Nenad, Poda Gennady, Al-awar Rima, Dixon Darren J., Brennan Paul E., Fedorov Oleg. . Discovery of an MLLT1/3 YEATS Domain Chemical Probe Angewandte Chemie International Edition. 86

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
MLLT1 / H3 5.85 myeloid leukemia Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 386.19 g/mol
HBA 7
HBD 2
HBA + HBD 9
AlogP 2.04
TPSA 80.04
RB 4
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
10.1002/anie.201810617 86 ENL
Q03111
H31
P68431
Biochemical assay alphascreen pIC50 (half maximal inhibitory concentration, -log10) 5.85
Ta Structure Name Drugbank ID
0.5650 Dabigatran DB14726
0.5380 N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE DB07973
0.5361 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE DB07974
0.5283 Glasdegib DB11978
0.5267 5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide DB07315
0.5207 Atevirdine DB12264
0.5152 USL-311 DB15265
0.5146 [4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium DB02269
0.5093 Niraparib DB11793
0.5056 METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE DB07689
0.5056 METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE DB07765
0.5032 Veliparib DB07232
0.4947 Ribociclib DB11730
0.4944 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide DB06938
0.4931 3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide DB03534